Target intelligence / Profile preview

Immune modulation via cutaneous stimulation

Molecular classification
Other (physiological or signaling process)
01

Overview

"Immune modulation via cutaneous stimulation" refers to the regulation of the immune response through sensory or physical stimulation of the skin. This process involves complex interactions between skin-resident immune cells (such as dendritic cells, mast cells, and T cells) and sensory nerves. Stimulation of cutaneous sensory fibers can lead to the release of neuropeptides (such as calcitonin gene-related peptide and substance P), which modulate the function of local immune cells, orchestrate inflammation, and influence disease processes such as infection, allergy, autoimmunity, wound healing, and cancer. This is a physiological process, not a distinct molecular entity, and encompasses diverse signaling pathways and cell types.

Other names
Cutaneous neuroimmune interactionSkin immune modulationNeuroimmune modulation via skin stimulation
02

Mechanism of action

Stimulation of skin sensory nerves can modulate cytokine production, immune cell migration, and inflammatory signaling via neuropeptide release (e.g., CGRP, substance P).\nElectrical or physical stimulation (e.g., transcutaneous electrical nerve stimulation) may indirectly alter immune responses via neural-immune pathways.

03

Biological functions

Immune responseInflammationSignal transductionHomeostasisAntimicrobial defense
04

Disease associations

InflammationInfectionAutoimmune diseaseAllergic diseaseWound healingCancer
05

Safety considerations

Nonspecific activation or suppression of immune responses may cause local or systemic inflammation, increased susceptibility to infection, or impaired wound healingPhysical or electrical cutaneous stimulation may lead to local skin irritation or pain
06

Interacting drugs

None specific; various immunomodulatory drugs, neuropeptides, and topical agents may modulate skin immunity, but none interact directly with "immune modulation via cutaneous stimulation" as a single entity
07

Biomarkers

None specific; broad immune markers such as cytokine levels (IL-1, IL-17, TNF, etc.) and immune cell populations (e.g., dendritic cells, T cells) may be used to assess cutaneous immune modulation

Beyond the preview

Go deeper on Immune modulation via cutaneous stimulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune modulation via cutaneous stimulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call